Filing Details

Accession Number:
0001415889-18-001643
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-14 20:25:01
Reporting Period:
2018-11-12
Accepted Time:
2018-11-14 20:25:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374328 Fitlife Brands Inc. FTLF Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643192 Judd Dayton C/O Fitlife Brands, Inc.
5214 S. 136Th Street
Omaha NE 68137
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-12 9,500 $0.46 1,128,601 No 4 P Indirect By Sudbury Holdings, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Sudbury Holdings, LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Acquisiton 2018-11-13 525 $0.00 1,141,304 $0.46
Common Stock Warrant Acquisiton 2018-11-12 342,391 $0.00 342,391 $0.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
525 2018-11-13 No 4 P Indirect
342,391 2018-11-13 2033-11-13 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 710,715 Direct
Common Stock 44,400 Indirect By SEP IRA
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 28, 2018.
  2. Shares of the Issuer's Series A Preferred Stock do not expire.
  3. The Reporting Person, through Sudbury Holdings, LLC, purchased 525 units ("Units") for $1,000 per Unit, with each Unit consisting of one share of the Issuer's Series A Preferred Stock, par value $0.01 per share, and a five-year warrant to purchase that number of shares of the Issuer's common stock equal to 30% of the shares of the Issuer's common stock issuable upon conversion of the Series A Preferred purchased by the Reporting Person.